{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:33:28Z","timestamp":1761676408008},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The objective is to determine localregional control (LRC), distant metastasis free survival, disease-free survival, overall survival (OS), and toxicity for patients with squamous cell carcinoma of the anus treated with definitive chemotherapy and intensity-modulated radiation therapy (IMRT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective review of patients treated using IMRT for squamous cell carcinoma of the anus at our institution since 2005. Patients with local recurrences were identified and reviewed. The Kaplan-Meier curves were used for LRC and OS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2005 to 2014, 52 patients were treated with IMRT-based chemoradiation for squamous cell carcinoma of the anus. Median dose to the primary tumor was 54 Gy. LRC, distant metastasis free survival, OS, and disease-free survival were 92.3%, 88.5%, 86.5%, and 84.6%, respectively, with a median follow-up of 20 months. Two local failures occurred at the anal primary site and 2 in the vulva. Despite subsequent palliative radiotherapy and chemotherapy, neither patient with a vulvar recurrence achieved disease control.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In a cohort of patients treated with IMRT-based chemoradiation, 2 vulvar recurrences were identified within the avoided external genitalia despite limited recurrence rates within the cohort overall. This experience suggests that for patients with a locally advanced primary tumor and bulky bilateral inguinal or pelvic disease, the in-transit vulvar dermal lymphatics may be at risk for subclinical involvement and subsequent recurrence. If substantiated by a similar pattern of recurrence at other institutions, the external genitalia may need to be reclassified from an avoidance structure to a clinical treatment volume in patients with locally advanced anal cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000322","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T16:07:28Z","timestamp":1468944448000},"page":"492-496","source":"Crossref","is-referenced-by-count":5,"title":["Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus"],"prefix":"10.1097","volume":"41","author":[{"given":"Hilary P.","family":"Bagshaw","sequence":"first","affiliation":[{"name":"Stanford University Hospital and Clinics, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Sause","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Gawlick","sequence":"additional","affiliation":[{"name":"Intermountain Colon & Rectal Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Tae","family":"Kim","sequence":"additional","affiliation":[{"name":"Intermountain Colon & Rectal Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Whisenant","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Cannon","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijrobp.2007.09.018","article-title":"Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer","volume":"70","author":"Cannon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2005.04.7225","article-title":"Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls","volume":"24","author":"Mendenhall","year":"2006","journal-title":"J Clin Oncol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0360-3016(03)00016-6","article-title":"Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study","volume":"56","author":"Vuong","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity","volume":"37","author":"Mitchell","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/COC.0000000000000009","article-title":"Intensity-modulated radiation therapy for anal cancer: results from a Multi-Institutional Retrospective Cohort Study","volume":"39","author":"Call","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"suppl","key":"R14-20230903","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201805000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:04:28Z","timestamp":1693710268000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201805000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000322","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}